From: The EXPLODING HUMAN with Bob Nickman SONNY MAYO, former guitarist for bands like Ugly Kid Joe and Snot, talks to me about getting STEM CELL THERAPY in Panama for a genetic heart condition. After two heart attacks and unpleasant side-effects from heart medications, Sonny was introduced to stem cell therapy through [...]
The heart attack I had at 44 was a massive one - a 3 on a scale of 4, so the damage was very bad. When you get a 3, you know at 4 you're dead. The whole left side was damaged, and it was the hospital's fault because back then when a woman went [...]
VIDEO – The Science of Mesenchymal Stem Cells and Regenerative Medicine – Arnold Caplan PhD (Part 6)
In part 6, Prof. Caplan discusses Trophic properties of mesenchymal stem cells; MSCs for heart disease; MSCs homing to heart injury site and also to skin incision site; MSCs limit left ventricular thinning following infarction; Trophic properties of MSCs: anti-apoptotic, anti-fibrotic, anti-scarring, angiogenic, mitotic; phase 1 data for allogeneic MSCs show fewer arrhythmias, prompt heart [...]
Leo Bockeria, Vladimir Bogin, Olga Bockeria, Tatyana Le, Bagrat Alekyan, Erik J Woods, Amalia A Brown, Thomas E Ichim and Amit N Patel Journal of Translational Medicine 2013, 11:56 doi:10.1186/1479-5876-11-56 Published: 5 March 2013 Heart failure is one of the key causes of morbidity and mortality world-wide. The recent findings that regeneration is possible in [...]
In addition to the possible use of Stem-Kine for restoration/maintenance of circulating endothelial progenitor cells, the publication discusses the possibility of using such cells from sources outside of the body, for example cord blood.
Adenosine inhibits chemotaxis and induces hepatocyte-specific genes in bone marrow mesenchymal stem cells
One of the major questions with adult stem cell therapy is how do the stem cells go to where they are needed?
TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology Meeting
The ability of TG-0054 to cause mobilization of EPC may support its use in other areas besides hematology. For instance the body may be able to grow new blood vessels around the areas of ischemia.
From the medical journal PloS ONE, scientists from the University of California Los Angeles reported that human blood cells derived from adult stem cells can be engineered into cells that can target and kill HIV-infected cells.
Doctors at the University of Texas Medical School at Houston have announced initiation of an efficacy-finding study in the area of heart failure using a "universal donor" stem cell product called "Prochymal".
The study demonstrated efficacy in the treated patients based on increase cardiac muscle contraction ability as compared to patients that had bypass surgery but did not receive stem cells.